what are the main glp 1 drugs Do Benefits of GLP-1 OutWeigh the Negatives? Evolution of GLP‐1 Receptor Agonists

These NAEs constituted over 5% of all reported AEs for this drug class, encompassing more than 12,000 cases

Even more notably, about a quarter of these women described their appetite reduction as "significant." 100% of the women in the Supresa group reported decreased hunger sensations Weight Management : While modest, the Supresa group showed statistically significant weight loss compared to placebo, losing 2.12 pounds over the 8-week period without any dietary restrictions

Retrieved from Rosenstock, J., Yabe, D., Cox, D., Li, J., Denning, M., Wu, W

Cardiovascular Drugs GLP-1 receptor agonists slow gastric emptying, which can delay the absorption of cardiovascular medications